IRAK2 and COVID-19: Interleukin 1 receptor-associated kinase 2 (IRAK2), upregulated in both COVID-19 and ICM, was associated with the upregulation of the FCER1 and TP63 pathways, both of which are associated with inflammation and immune activation (See Appendix A, Figure A2A) [46,47].